Preferences in the management of high-risk prostate cancer among urologists in Europe: results of a web-based survey

Author:

Surcel Cristian I.1,Sooriakumaran Prasanna23,Briganti Alberto4,De Visschere Pieter J.L.5,Fütterer Jurgen J.6,Ghadjar Pirus7,Isbarn Hendrik8,Ost Piet9,Ploussard Guillaume10,van den Bergh Roderick C.N.11,van Oort Inge M.12,Yossepowitch Ofer1314,Sedelaar J.P. Michiel12,Giannarini Gianluca15ORCID,

Affiliation:

1. Centre of Uronephrology and Renal Transplantation; Fundeni Clinical Institute; “Carol Davila” University of Medicine and Pharmacy; Bucharest Romania

2. Surgical Intervention Trials Unit; Nuffield Department of Surgical Sciences; University of Oxford; Oxford UK

3. Department of Molecular Medicine and Surgery; Karolinska Institute; Stockholm Sweden

4. Department of Urology; Urological Research Institute; Vita-Salute University San Raffaele; Milan

5. Department of Radiology; Ghent University Hospital; Ghent Belgium

6. Department of Radiology; Radboud University Medical Centre; Nijmegen The Netherlands

7. Department of Radiation Oncology; Charité Universitätsmedizin Berlin; Berlin Germany

8. Department of Urology; University Medical Center Hamburg-Eppendorf; Hamburg Germany

9. Department of Radiation Oncology and Experimental Cancer Research; Ghent University Hospital; Ghent Belgium

10. Department of Urology; CHU Saint-Louis; Assistance Publique - Hôpitaux de Paris; Université Paris Est Creteil; Paris France

11. Department of Urology; University Medical Centre Utrecht; Utrecht The Netherlands

12. Department of Urology; Radboud University Medical Centre; Nijmegen The Netherlands

13. Department of Urology; Rabin Medical Center - Beilinson; Petach-Tikva Israel

14. Sackler Faculty of Medicine; University of Tel Aviv; Tel Aviv Israel

15. Department of Experimental and Clinical Medical Sciences; Urology Unit, University of Udine; Udine Italy

Publisher

Wiley

Subject

Urology

Reference30 articles.

1. Secondary therapy, metastatic progression, and cancer-specific mortality in men with clinically high-risk prostate cancer treated with radical prostatectomy;Yossepowitch;Eur Urol,2008

2. High-risk prostate cancer in the United States, 1990-2007;Cooperberg;World J Urol,2008

3. Pathological results and rates of treatment failure in high-risk prostate cancer patients after radical prostatectomy;Walz;BJU Int,2011

4. European Association of Urology Guidelines on Prostate Cancer http://www.uroweb.org

5. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology, Prostate Cancer Version 1 2014 http://www.nccn.org

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3